YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition

about

YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition

Item

http://www.wikidata.org/entity/Q38693620

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

YKL-40 promotes the migration ...... thelial mesenchymal transition

@en

type

Item

label

YKL-40 promotes the migration ...... thelial mesenchymal transition

@en

prefLabel

YKL-40 promotes the migration ...... thelial mesenchymal transition

@en

P1476

YKL-40 promotes the migration ...... thelial mesenchymal transition

@en

P2093

Dongwen Wang

http://www.w3.org/2001/XMLSchema#string

Hailong Hao

http://www.w3.org/2001/XMLSchema#string

Hongyu Liu

http://www.w3.org/2001/XMLSchema#string

Huiqing Chen

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Liwu Xie

http://www.w3.org/2001/XMLSchema#string

Tao Bai

http://www.w3.org/2001/XMLSchema#string

P2860

Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma

A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Serum YKL-40, a new prognostic biomarker in cancer patients?

Novel secondary hormonal therapy in advanced prostate cancer: an update.

Epithelial-mesenchymal transition in hepatocellular carcinoma.

YKL-40/CHI3L1 drives inflammation on the road of tumor progression.

P304

3749-3757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28861166

http://www.w3.org/2001/XMLSchema#string

P932

5575189

http://www.w3.org/2001/XMLSchema#string